Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma

Author:

Wang B-Y1234ORCID,Wu S-C5,Chen H-C1,Hung W-H1,Lin C-H6,Huang C-L1,Chen H-S7

Affiliation:

1. Division of Thoracic Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan

2. School of Medicine, Chung Shan Medical University, Taichung, Taiwan

3. Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung, Taiwan

4. School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

5. Institute of Health and Welfare Policy, National Yang-Ming University, Taipei, Taiwan

6. Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan

7. Department of Health Care Administration, Chang Jung Christian University, Tainan City, Taiwan

Abstract

Abstract Background Whether there is a difference in survival after neoadjuvant chemoradiotherapy plus surgery (CRT-S) compared with definitive chemoradiotherapy (dCRT) in patients with locally advanced oesophageal squamous cell carcinoma (SCC) remains controversial. Methods Patients with SCC who underwent curative treatment from 2008 to 2014 were identified from the Taiwan Cancer Registry. Propensity score matching was undertaken to balance pretreatment clinical variables. Overall survival was compared between patients undergoing CRT-S or dCRT. Univariable and multivariable analyses were performed to identify prognostic factors for overall survival. Results A total of 5832 patients with clinical stage II and III oesophageal SCC receiving CRT-S (1754) or dCRT (4078) were included. After propensity score matching, each group included 1661 patients. The 3-year overall survival rate for patients treated with CRT-S was 41·1 per cent compared with 17·9 per cent for those who had dCRT (P < 0·001). In multivariable analysis, treatment modality was an independent prognostic factor in the overall cohort before propensity score matching: hazard ratio 0·45 (95 per cent c.i. 0·40 to 0·51) for CRT-S versus dCRT (P < 0·001). In separate analyses of patients with clinical stage II and those with stage III disease, CRT-S was associated with significantly better overall survival than dCRT. Conclusion Neoadjuvant chemoradiotherapy and oesophagectomy is associated with better overall survival than dCRT in patients with stage II and III oesophageal SCC.

Publisher

Oxford University Press (OUP)

Subject

Surgery

Reference30 articles.

1. Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan;Lu;Cancer Causes Control,2010

2. Outcome of patients with esophageal cancer: a nationwide analysis;Chen;Ann Surg Oncol,2013

3. Comparison of pathologic stage in patients receiving esophagectomy with and without preoperative chemoradiation therapy for esophageal SCC;Wang;J Natl Compr Canc Netw,2014

4. Impact of treatment modalities on survival of patients with locoregional esophageal squamous-cell carcinoma in Taiwan;Chen;Medicine (Baltimore),2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3